Gonçalo Ferraz Costa: Modern Thrombolytic Strategies and the Risk–Benefit Balance in Valve Thrombosis
Gonçalo Ferraz Costa, Cardiologist at ULS de Coimbra, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”TL;DR: In obstructive prosthetic valve thrombosis, surgery achieves higher immediate valve-function restoration, while contemporary low-dose/slow-infusion alteplase protocols may offer comparable efficacy with a potentially more favorable risk–benefit profile in selected patients.
Treatment should be individualized.
I’m pleased to share our latest publication in the Journal of Thrombosis and Haemostasis: ‘Fibrinolysis versus Urgent Surgery in Obstructive Prosthetic Valve Thrombosis: Updated Evidence from a Systematic Review and Meta-Analysis.’
1.Obstructive prosthetic valve thrombosis (PVT) is life-threatening, and the optimal first-line strategy remains debated. In this updated meta-analysis (12 observational studies + 1 RCT; n=1300), we found:
- No statistically significant difference in in-hospital mortality
- Surgery associated with higher rates of complete restoration of valve function
- Fibrinolysis associated with higher stroke/systemic embolism and recurrent PVT
- No statistically significant difference in major bleeding or follow-up mortality
2. However, in analyses focusing on contemporary alteplase-based protocols (low-dose/slow-infusion regimens), results suggest:
- Lower in-hospital mortality
- Comparable efficacy to surgery
- Meta-regression indicating better outcomes with modern protocol characteristics
Clinical implication: the ‘fibrinolysis vs surgery’ debate is no longer binary.
Contemporary thrombolytic strategies may shift the risk–benefit balance in selected patients.
Decisions should integrate embolic risk, surgical risk, valve position, hemodynamic stability, and institutional expertise.
Special thanks to Bernardo Lisboa Resende and Emidio Mata for their outstanding work!”
Title: Fibrinolysis versus Urgent Surgery in Obstructive Prosthetic Valve Thrombosis: Updated Evidence from a Systematic Review and Meta-Analysis
Authors: Bernardo Resende, Emídio Mata, Margarida Castro, Ana Marta Pinto, Sílvia Ribeiro, João Gameiro, António Lourenço, Gonçalo Ferraz-Costa, Lino Gonçalves
Read the Full Article on JTH

Stay updated on all scientific advances with Hemostasis Today.
-
May 27, 2026, 04:47Daniel Torrent: The Overlooked Epidemic of Post-Thrombotic Syndrome
-
May 27, 2026, 04:45Graziella Pompei: Is Aspirin Still a Valid Alternative to Clopidogrel in PCI with DES Implantation?
-
May 27, 2026, 04:40Kausik Ray: Phase 1 Trial Highlights Anti-Inflammatory Effects of Ruvonoflast
-
May 27, 2026, 04:29Francisco Chacón-Lozsán: High-Sensitivity Troponin and the Evolving Management of NSTEMI
-
May 27, 2026, 04:14Michael R. Jaff: HI-PEITHO Trial and NEWS Score Insights on Advances for Intermediate-Risk Pulmonary Embolism
-
May 26, 2026, 16:45Ashley George: Take the Leap for Thrombosis UK
-
May 26, 2026, 16:40Hamed Helisaz: Machine Learning for Detecting Missing Heart Medications
-
May 26, 2026, 15:32Haroun Gajraj: Brown Marks After Microsclerotherapy – What Every Practitioner Needs to Know
-
May 26, 2026, 15:29Jacqueline van Paassen: Lack of Essential Clinical Data in DOAC Prescriptions in Community Pharmacies